Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
2.460
+0.210 (9.33%)
Jun 6, 2025, 4:00 PM - Market closed
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $175.06 million as of June 9, 2025. Its market cap has decreased by -47.61% in one year.
Market Cap
175.06M
Enterprise Value
-43.20M
1-Year Change
-47.61%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $175.06M, a decrease of -77.64%. That is a compound annual growth rate of -33.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 175.06M | 13.04% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |